Why the study?
Does long-term cardiac contractility modulation (CCM) therapy prevent progressive LV dysfunction and remodeling in a canine model of chronic heart failure?
Population
12 dogs with chronic heart failure produced by multiple sequential intracoronary microembolizations
Comparison
Non-excitatory cardiac contractility modulation… vs Control dogs with heart failure that did not…
Design
Preclinical
Follow-up
3 months
Authors
Loading...
CCM may attenuate remodeling in experimental HF; leaves open translation to patients.
Does long-term cardiac contractility modulation (CCM) therapy prevent progressive LV dysfunction and remodeling in a canine model of chronic heart failure?
Long-term cardiac contractility modulation (CCM) therapy prevents progressive LV dysfunction and attenuates global LV remodeling in a canine model of chronic heart failure.
Morita et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: